INISOTCIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
RADNOSTIX INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-6.00%)
Close on Oct 19, 2026
- Market cap
- $24.87M
- P/E (TTM)
- –
- Dividend yield
- –
RADNOSTIX INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theranostics Products [Member] | $5.62M | $6.45M | $6.84M | $6.93M | $7.62M | $7.89M | $8.01M | $8.07M | $7.42M | $6.99M | $6.84M | – | 50.1% | -26.2% |
| Calibration & Reference Products [Member] | $3.85M | $3.80M | $4.25M | $4.72M | $4.69M | – | $3.52M | – | – | – | – | – | 34.3% | -17.9% |
| Cobalt Products [Member] | $1.51M | $1.69M | $1.75M | $2.24M | $2.29M | $2.20M | $2.37M | $1.74M | $1.26M | $1.11M | $1.04M | $1.40M | 13.4% | -34.1% |
| Medical Device Products [Member] | $248.30K | $265.43K | $228.95K | $185.13K | $119.38K | $61.29K | $8.66K | $0 | $0 | $0 | $0 | – | 2.2% | +108.0% |
| Fluorine Products [Member] | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Radiochemical Products [Member] | – | – | – | – | – | – | – | – | – | – | – | $6.77M | – | – |
| Nuclear Medicine Products [Member] | – | – | – | – | $4.69M | $4.08M | $3.52M | $3.34M | $3.46M | $3.98M | $4.39M | $4.10M | – | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US [Member] | – | – | – | – | – | – | – | $2.13M | $2.14M | $2.20M | $2.24M | $1.74M | – | – |
| United States | – | – | – | – | – | – | – | $11.01M | $10.00M | $9.88M | $10.02M | $10.53M | – | – |
From the segment and revenue-disaggregation notes of Radnostix's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.